Video

Stay tuned for Live Conference Coverage from ASCO 2011

Author(s):

Onclive Team
Conference|ASCO Annual Meeting

ASCO 2011, June 3-7, 2011 McCormick Place, Chicago, IL

ASCO 2010 Meeting in Chicago

Stay Tuned for the ASCO Annual Meeting

June 3 — 7, 2011 | McCormick Place | Chicago, IL

Sign up to attend here:

Register

View Abstracts:

ASCO 2011 Abstracts

Related Videos
Sujith Samarasinghe, MD
Suzanne Trudel, MSc, MD
Consuelo Bertossi, MD
Michael R. Grunwald, MD, FACP
Manali Kamdar, MD
Ibrahim Aldoss, MD
Timothy Hughes, MD, MBBS, FRACP, FRCPA
Ana Christina Garrido-Castro, MD
Jennifer R. Eads, MD, physician lead, GI Cancer Research, director, National Clinical Trials Network, Abramson Cancer Center, University of Pennsylvania, associate professor, clinical medicine (hematology-oncology), Penn Medicine, Perelman Center for Advanced Medicine
Jean-Marc Classe, MD, PhD, Nantes Université
Related Content
Michael Wang, MD, of The University of Texas MD Anderson Cancer Center
June 17th 2024

Frontline Acalabrutinib/BR Regimen Significantly Improves PFS in Mantle Cell Lymphoma

Stephen Opat, of Monash Health
June 17th 2024

Sonrotoclax Plus Zanubrutinib Is Safe, Efficacious in Relapsed/Refractory CLL/SLL

Suzanne Lentzsch, MD, PhD, professor, clinical medicine, director, Multiple Myeloma and Amyloidosis Program, College of Physicians and Surgeons, Columbia University Medical Center and NewYork-Presbyterian Hospital
June 17th 2024

Linvoseltamab Elicits Deep, Durable Responses in R/R Multiple Myeloma

Ruben A. Mesa, MD, FACP, of Atrium Health Levine Cancer Institute
June 17th 2024

Prospective Analysis Highlights Patterns of Progression to Myelofibrosis Following Essential Thrombocythemia Diagnosis

Jing-Zhou Hou, MD, PhD, of UPMC Hillman Cancer Center
June 17th 2024

Acalabrutinib and Zanubrutinib Both Best Ibrutinib in Real-World Safety and Efficacy CLL/SLL Outcomes

William Wierda, MD, PhD
June 17th 2024

Lower Tumor Burden Associated With Improved ORR With Liso-Cel in R/R CLL/SLL